Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board
/PRNewswire/ -- Amaroq Therapeutics, a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer, is progressing...
Source: prnewswire.com